KDM1A inhibition in AML leads to the transcriptional activation of integrin subunit alpha M (ITGAM) and cluster of differentiation 86 (CD86) myeloid lineage genes, reducing AML cell proliferation. Here, CD86 is linked to acute myeloid leukemia.